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1. INTRODUCTION 
Dental caries is a globally occurring disease, which has exhibited some signs of 
decreasing but still causes problems at the individual as well as the national 
public health level. The caries index in Estonia, especially among children, is 
still higher than in Scandinavia, where governments have contributed to caries 
prevention programmes and the awareness of people is high. 
Caries is a dynamic process, which is hidden before the damage also 
becomes visible for people without special education and culminates at the end 
of a negative scenario with the formation of a cavity. It is a prolonged process, 
requiring a couple of years, and therefore, needs long-term caries prevention 
methods. 
Contemporary theories support the role of sugar consumption in the 
development of caries, and therefore, the replacement of cariogenic sugars with 
non-cariogenic substances, like xylitol or other less cariogenic sugar alcohols, is 
one way to reduce the risk of caries. 
Although the history of polyols as non-cariogenic sweeteners is long – 
studies about the effect of xylitol on caries prevention have been carried out 
over decades and have demonstrated evidence-based success. The preventive 
effect of polyols has not always been confirmed or approved. The complexity of 
this is concealed in the numerous factors of its influence, which need a well-
designed study and a multifaceted assessment of the results. 
However, there is not much data about alternative sugars like erythritol, 
which has only been researched in short-term studies. The interest of this 
clinical trial was to investigate and compare the influence and effectiveness of 
the long-term consumption of different polyols on mixed dentition. 
The present study was designed as a double-blind randomised controlled 
prospective clinical trial with 3-year intervention (polyols consumption) among 
elementary school level children which included annual clinical examination of 
the participants in the Department of Stomatology at the University of Tartu. 
3
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2. REVIEW OF THE LITERATURE 
2.1. Dental caries 
2.1.1. Dental caries development 
Dental caries is a world-wide public health problem caused by specific oral 
bacteria that can affect all dental hard tissues (Kidd 2005). In particular, 
acidogenic bacteria can cause demineralization and eventual devitalisation of 
the teeth. The cariotic process begins when acid produced by bacterial 
metabolism of certain dietary fermentable carbohydrates dissolves Ca2+ and 
inorganic phosphate ions present in the hydroxyapatite mineral that is a main 
inorganic component of enamel (Fejerskov and Kidd 2008). Dissolution of this 
mineral normally starts when the pH of dental plaque decreases below 5.5. 
Because the salivary buffer mechanism attempts to repair the damage caused by 
acids, the counteracting remineralisation process controlled by saliva will set off 
when the plaque pH returns to the neutral zone (Marsh and Nyvad 2008). 
In summary, the pathological factors involved in the caries process include 
specific cariogenic bacteria, the presence of fermentable carbohydrates in food, 
and various salivary effects. Dental caries may be regarded as a main cause of 
tooth loss at younger ages from childhood to adult life. 
 
2.1.2. Formation of dental plaque 
The human body is a place for a large number of different micro-organisms. 
Hundreds of species of transit flora have been detected in the mouth, many of 
them representing the permanent microbiota. A particular group of bacteria, 
called mutans streptococci, has been associated with the initiation of dental 
caries (Tanzer et al. 2001). These organisms include Streptococcus mutans and 
Streptococcus sobrinus whose differentiation in dental plaque and saliva has 
become possible by means of laboratory tests that have turned out to be time-
consuming and costly (Seki et al. 2006). Certain aciduric and acidogenic lacto-
bacilli and a number of other bacteria also contribute to the overall structure and 
metabolism of dental plaque (Avila et al. 2009, Takahashi and Nyvad 2011). 
The tooth enamel is normally covered by a thin layer of saliva origin. This 
biofilm, called pellicle, normally serves as the first stage of plaque formation. 
Electron microscopic studies have shown that the first bacterial cells, following 
thorough professional oral prophylaxis, normally adhere to the pellicle. Some of 
the first colonisers include streptococci, notably S. oralis, S. sanguis and S. 
mutans, which normally comprise less than one per cent of all microbes present 
in the average dental plaque (Marsh and Martin 2000, Featherstone 2004, 
Garcia-Godoy and Hicks 2008). 
The biofilm community on the tooth surface comprises multiple combi-
nations of colonies from different species of microbes, an extracellular matrix, 
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voids and fluid channels. Dental plaque is a vital, changing unit where variable 
physic-chemical interaction between bacteria and the substrate take place 
(Rosan and Lamont 2000).  
The specific role of mutans streptococci in dental caries formation is mani-
fested by their ability to convert the glucose molecules into gel-like extra-
cellular dextran – polymers that constitute the immediate outer capsule of those 
bacterial cells. These dextran molecules are characterised by their ability to bind 
to the pellicle or sometimes directly to the hydroxyapatite structure (reviewed 
by Law et al. 2007). The mutans bacteria are able to exploit the glucose and also 
the sucrose molecules for the dextran formation. Owing to the high chemical 
energy present in the glycosidic bond of the sucrose molecule, sucrose 
constitutes a very favourable substrate for plaque dextran formation (Jenkinson 
and Lamont 1997). The most important caries-associated acids formed by 
plaque during bacterial metabolism normally include lactic acid, propionic acid 
and acetic acid (Lamont et al. 2006). 
 
2.1.3. Risk factors of caries 
Caries as a multifactorial preventable disease has multiple risk factors including 
acidogenic bacteria, previous caries, dietary carbohydrates, low fluoride intake, 
salivary dysfunction, low socioeconomic status and so on (reviewed by Harris 
et al. 2004). 
 
2.1.3.1. Early childhood caries 
Caries among preschool children has been shown to be a risk factor for caries in 
their permanent dentition (Tinanoff et al. 2002, Olak et al. 2007). The 
combination of non-cavitated caries lesions in the permanent dentition, 
cavitated lesions in primary molars and past caries experience variables have 
been suggested as predictors of caries (Zhang et al. 2006, Sagheri et al. 2009).  
 
2.1.3.2. Carbohydrates 
The frequency of the consumption of fermentable carbohydrates is a critical 
factor in caries activity, as described above. The type of carbohydrate, form of 
carbohydrate contained in the product, and contact time with the tooth surface 
are the key factors during the consumption of carbohydrates. Hence, studies 
have shown the role of glucose in the initial caries development process 
(Moynihan et al. 2004, 2014), and a positive association between caries and the 






Previous studies, summarized by Petersen and Lennon (2004), have shown that 
higher intake of fluorides decreases caries. The development of dental caries is 
strongly related to fluoride levels in drinking water (Vogel 2011, Peckham and 
Awofeso 2014), the topical application of fluorides (Ijaz et al. 2010, Chestnutt 
et al. 2012) and/or using fluoridated oral hygiene products (Marinho et al. 2004, 
Petersen and Lennon 2004, Rugg-Gunn and Banoczy 2013, Cury and Tenuta 
2014). 
 
2.1.3.4. Socioeconomic status 
A number of researchers have reported that high frequency carbohydrate intake 
in combination with inadequate oral hygiene is more common in groups with 
lower socioeconomic status, especially in early childhood (Hallett and 
O’Rourke 2003, Petersen 2005, Naidu et al. 2013). The lowest income recorded 
by Statistics Estonia 2010 (Ingel et al. 2010) is in the South-East (Valgamaa, 
Võrumaa, Põlvamaa), North-East (Ida-Virumaa) and Central Estonia (Jõgeva-
maa), which partially coincides areas with low fluoride levels in drinking water 
and a high prevalence of caries. 
 
 
2.2. Caries registration 
2.2.1. Epidemiology of dental caries in Estonia 
The most widely used index for assessing caries experience is the DMFT index, 
where D marks the number of decayed, M missing and F filled permanent teeth 
(Larmas 2010). The corresponding index for primary teeth is dmft. The DMFT 
index has been used in dental epidemiology for over 70 years to describe caries 
experience. The data are collected worldwide by the WHO Data Bank. 
In Estonia, various non-representative studies (Wolf et al. 1996, Alanen et al. 
2000, Dragheim et al. 2000, Olak et al. 2007) have been carried out to find out 
caries prevalence and experience in different age groups. The government has 
funded some limited projects (Saag et al. 1998); other data have been received 
during the above-mentioned surveys or clinical studies. However, the data are 
incomplete and do not include the total population and not all age groups. 
The prevalence of caries (in of children with dmft>0) in primary dentition 
among very young children aged 2–4 years, reported by Olak et al. (2007), was 
44% for boys, 34% for girls, and as a mean 41.6% (p=0.05). The prevalence of 
caries varied from 30.3% to 56.2% depending on the region of the study. The 
higher prevalence was reported in southern areas (Valga, Võru). Early 
childhood caries (baby bottle caries) has been found to differ significantly 
between geographical areas – from 14.0% to 31.2% (p=0.01), being extremely 
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high in Võru. The percentage of children without caries (dmft=0) was 37% at 
24–35 months and 18% at 36–47 months (p=0.005) (Olak et al. 2007). 
The study in municipal schools in Tartu showed a prevalence of 83.8% 
(dmfs 7.7) in primary dentition among 7-year-olds compared to 62.1% (dmfs 
5.3) in Danish children of the same age (Dragheim et al. 2000). The caries 
prevalence in Estonia at the age of 12 was 69.5% and increased rapidly to 
81.0% among 15-year-olds (Wolf et al. 1996). 
The WHO reported the average number of teeth with caries or caries 
experience in permanent dentition (DMFT) among 12-year-olds in Estonia as 
having been high – 4.1 until the early 1990s, but this has decreased since 
regaining independence being 2.7 in 1998 (2.6 by Kõll-Klais et al. 2004). The 
latter is also the European average (DMFT 2.6), being higher than in 
Scandinavia but lower than in the other Baltic countries (Whelton 2004, 
Gudkina et al. 2008, Patel, 2012). 
The dmft/DMFT has been shown to vary in different parts of Estonia. The 
highest indices in permanent dentition (up to 6) among 12-year-olds are in the 
central-north and in the south-eastern areas. Wolf (1996) reports the mean 
DMFT among 14 to 17-year-old pupils was 3.7 in Tartu and 7.0 in Tallinn. 
There could be several reasons for this variation, including risk factors which 
are described above. 
 
2.2.2. ICDAS II caries registration system 
The DMFT index does not include and does not describe the need for the 
treatment of early caries lesions. Clinical studies, however, require the 
registration of early caries lesions stages as well. For these purposes, the 
International Caries Detection and Assessment System (ICDAS II) was 
developed by a group of international caries research experts. The purpose was 
described by Ismail et al. (2007) – to integrate several new caries recording 
systems and to create an evidence-based caries detection and assessment 
system, which would be oriented at caries prevention. 
Multiple studies (Ismail et al. 2007, Kühnisch et al. 2008) have analysed or 
compared the ICDAS II system in clinical trials. The weaknesses of the ICDAS 
system include poor visual control of the contact surfaces and occlusal surfaces 
without radiographs (Diniz et al. 2009), and because it is highly time consuming 
(Ormond et al. 2010 and Aidara et al. 2011). Some researchers (Bertella et al. 
2013) report the necessity of radiographs prior to the final decision for 
underlying dark shadows (ICDAS code 4) on permanent molars and in occlusal 
caries. 
At early school age, only the first permanent incisors and molars have 
erupted. The ICDAS system has been declared to diagnose proximal caries of 
molars provided the proximal surface is opened for visual control (e.g. a 
primary molar has exfoliated and a permanent premolar has not erupted yet) 
(Ekstrand et al. 2011). Recent studies (Isamil et al. 2007, Diniz et al. 2009, 
4
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Mendes 2010) have shown that pre-cleaned and dried tooth surfaces and the 
comprehensive training of observers improves caries detection. The testing of 
the ICDAS II system continues, and researchers emphasize the importance of 
preliminary training and necessity of further development before using those 
codes in epidemiological surveys (de Amorim 2012). 
The ICDAS II system is appropriate to record and to monitor the progress of 
the caries lesions during long-term trials both in primary or permanent dentition 
(Pitts 2009). Hence, it can be argued that combining examination using the 
ICDAS system with alternative diagnostic methods in clinical work could 
improve the detection of cariotic lesions (Mitropoulos et al. 2010). 
 
 
2.3. Caries prevention 
The control or elimination of caries risk factors, in addition to regular oral 
hygiene procedures through different methods makes it possible to prevent and 
control the cariotic process. Fluorides, salivary calcium, phosphates, proteins 




Fluorides are chemical compounds which contain the element fluorine. The 
importance of fluorides in caries prevention is due to the higher resistance of 
fluorapatite − the enamel tissue where fluoride ions replace calcium to tolerate a 
lower pH. 
 
2.3.1.1. Systemic delivery of fluorides 
The systemic, regular long-term intake of fluorides takes place through 
everyday water consumption (mainly through drinking water). The level of 
fluorides in the groundwater in Estonia varies extensively from 0 (south-eastern 
region) to 7 mg/L (in the west, Silurian-Ordovician aquifer system), presented 
by Karro et al. (2006) and Indermitte et al. (2007). In addition to the south-
eastern area where the fluoride level is low (0–0.3 mg/L), there are also two 
towns (Tallinn and Narva) with relatively low concentrations of fluorides 
because surface water is used instead of groundwater. This, however, has an 
effect on the development of caries in children. 
The children growing up in areas with optimal (0.8–1.2 mg/L) or high levels 
(>1.2 mg/L) of fluorides in their drinking water have a higher content of 
fluorides in the enamel surface and thus higher resistance to the dissolving of 
calcium and inorganic phosphate ions (pH up to 4.5 against the 5.5 in case of 
natural enamel). There is a statistically significant correlation between fluoride 
levels in drinking water and caries development (systemic effect) (McDonagh et 
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al. 2000, Armfield 2010). Systemic intake of fluorides is prolonged, and there-
fore, a principle factor in the development of resistant enamel structure before 
tooth eruption. 
The concentration of the fluoride above the optimum level during the tooth 
developmental phase can affect the normal growth of the teeth and increases the 
risk of the dental fluorosis. Critical time is from infancy and continues up to 8 
years – the period of the active development and mineralization of permanent 
tooth germs (before eruption). Symptoms of fluorosis, as they were described 
by Thylstrup and Fejerskov in 1978, vary from the fractional, unnoticeable 
white opaque areas or stripes (mild form) to severe forms where all tooth 
surfaces of all teeth are affected – discoloured, mottled (brown strain) areas and 
pitting of the teeth. 
In 2004, 4% of the population of Estonia (nearly 4,000 citizens) had 
excessive exposure to natural fluoride (over 4 mg/L), mostly in the western and 
central part of Estonia (Indermitte at al. 2009). Since 2004, the reduction 
methods have been applied to optimise the content of fluorides in public water 
supplies, which have been successful due to the implementation of osmosis 
technology and bore wells have started using new groundwater layers. In 2012, 
only 380 consumers still had an extremely high exposure to fluorides (Inder-
mitte et al. 2014). 
The systemic delivery of fluorides is individual because of the different 
levels of fluoride in the drinking water in Estonia and the place of residence in 
childhood always needs specifying to clarify the overall intake of fluorides 
during the development of teeth. 
 
2.3.1.2. Topical fluoride intervention 
Fluoride ions are highly active, and therefore, they have a tendency to fixate on 
hard tissues, including enamel. The formation of fluorapatite is a result of de- 
and remineralisation processes during the substitution where the hydroxyl ion in 
enamel is replaced by a fluoride ion (Kutsch et al. 2013). 
Topical intake of fluorides could be professional applications (with fluoride 
varnishes etc.) or individual (mostly daily use of fluoridated toothpaste). 
Numerous studies in Cochrane systematic reviews have demonstrated the 
preventive effect of topical methods on permanent teeth while the evidence is 
weak or moderate and inconsistent in primary dentition (Tubert-Jeannin et al. 
2011, Marinho et al. 2002, 2003 and 2013). An extra topical application of 
fluoride varnish in addition to daily tooth brushing with fluoride toothpaste 
(1,000 ppm) may have a slight effect in primary dentition only in high-risk 
groups (Agouropoulos et al. 2014). 
The impact of fluorides is complex, and therefore, calculating the actual 
effect is complicated, depending on concentration, dose, frequency and 
combination of fluorides, earlier caries severity, oral hygiene skills, supervised 
tooth brushing and so on (Marinho et al. 2004, Walsh et al. 2010). 
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2.3.2. Polyols (sugar alcohols, alditols) 
The general formula of sugar alcohols alias polyols alias alditols is 
H(HCHO)n+1H – the difference is in chain length. They are polyalcohols derived 
by the reduction of an aldose-polyol dehydrogenase (NADP+), which reversibly 
converts aldoses to alditols. Alditols are naturally occurring sweet substances 
found in low amounts in plants, micro-organisms and animal bodies. 
Industrially they are often obtained on a large scale through the hydrogenation 
of sugars (except the erythritol) (Monedero et al. 2010). 
All polyols can be divided into hypo- or non-acidogenic groups, based on the 
fermentation by oral microbiota (in vitro) evident in the pH measured in dental 
plaque. The plaque pH, measured in vivo, is an indicator of the cariogenicity of 
polyols or food products. If the plaque pH decreases below 5.5 (which is 
associated with initial caries) after exposure to fermentable sugar alcohols 
because of the formation of organic acid in dental plaque, this product is 
classified as cariogenic. In comparison to this, the alditols are low- or non-
cariogenic substances. The anti-caries and/or caries preventive characteristics of 
polyols are of interest in the field of caries prevention. 
A systematic review provided by Moynihan and Kelly (2014), based on 
clinical studies, supports the evidence of the positive effects of the combination 
of dosage and frequency of fermentable dietary carbohydrates, chiefly sucrose 
consumption and caries level. This has brought about an increase in the 
popularity of polyols in food products. The cause for this, however, is the food 
industry’s interest in finding a suitable, less cariogenic and low-caloric 
replacement for sugars. The most common alternative is sorbitol, but the trials 
in oral biology research continue testing and comparing it with other alditols-
based sugar-free food substances. 
Another relevant factor in polyols is the level of sweetness, which varies in 
the case of different polyols. The relative sweetness of common sugar alcohols 
is reported in Table 1. In addition, the molecular parameters, which determine 
properties of sugar alcohols, are significantly different. The metabolism of 
common sugar alcohols is well studied, and therefore, it is known that alditols 
are mostly not metabolised by oral microbiota and polyols are only partially 
absorbed in the small intestine (up to 80% for sorbitol). The absorption of 
dietary polyols in the gastrointestinal tract can be active or passive depending 
on the molecular size and the chemical specificities of the sugar alcohols (Table 
1). Payne et al. (2012) have reported that this absorption depends on the degree 
of polymerisation. 
When polyols dissolve, it has a cooling effect in the mouth, which is a result 
of an endothermic process, negative heat from the solution. Xylitol and 
erythritol have the strongest cooling effect, which can cause discomfort for 
some people. One way to relieve this is to combine different agents. Polyols are 
non-reactive, and therefore, they can be mixed with other sweeteners in 
products. 
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The toxicity of polyols has been the topic of several studies. However, 
earlier studies have been based on animal subjects but the metabolism in the 
human body does not have exactly the same pathways as in animals (Lina et al. 
1996). Those experiments often exposed extremely high doses of the test 
components. Hence, animal tests do not allow us to infer that the toxicity for 
humans is similar. 
The well-known side effect of almost all polyols is gastrointestinal distress 
via a laxative effect. Tolerance of polyols varies depending on the type of sugar 
alcohol, the quantity consumed and individual resistance. Side-effects are 
absent up to a specific amount consumed. Common complaints after taking 
large doses of polyols include the following intestinal symptoms: bloating, 
diarrhoea, abdominal pain because of bowel movements (irritable bowel 
syndrome) and nausea. Mannitol lingers in the intestinum longer than other 
sugar alcohols, and therefore, causes side-effects more often. One well-tolerated 
polyol is erythritol. When avoiding the consumption of excessive amounts of 
products with sugar alcohols, they are perfectly safe. 
Allergic reactions against polyols are rare. Only a couple of cases, such as 
urticarial, have been reported by Hino et al. (2000) and Yunginger et al. (2001). 
Some other symptoms, such as hives, skin rashes, difficulty breathing, swelling 
of the mouth and hands, dizziness, vomiting, weakness, and even anaphylactic 
shock after consuming erythritol or others sugar alcohols have been reported by 
Shirao et al. in 2013. 
The aim of caries prevention using polyols is to replace the carbohydrates 
after a meal with some less-cariogenic sugar alcohols. The most effective 
method is exposure to a polyol immediately after eating, indicatively 4–5 times 
per day. Prolonged contact between the product and the teeth is required – not 
less than 2–3 minutes. 
The most widely used and tested polyols are xylitol (a pentitol type sugar 
alcohol), sorbitol, mannitol (hexitol), maltitol, lactitol (12-carbon polyols) and 
mixed products (van Loveren 2004). The newest promising subject is erythritol 
(tetritol), tested by Kawanabe (1992) and Mäkinen (2001). 
 
Table 1. Properties of sorbitol, xylitol and erythritol (modified from de Cock and 
Bechert 2002) 
Sugar alcohol Relative 
sweetness to 
sucrose 
Food energy (kcal/g) Maximum dose of polyols 
not causing laxative side 
effect (g/kg body wt) 
Sorbitol 0.5...0.6 2.4 (EUR) … 2.6 (US) 0.17…0.24 
Xylitol 0.9...1.0 2.4 0.3 






2.3.2.1. Sorbitol (glucitol) 
Sorbitol is a 6-carbon hexitol type polyol (C6H14O6). It occurs naturally and is 
produced synthetically from glucose. Sorbitol is a common ingredient in (oral) 
hygiene products (e.g. in toothpastes and mouthwashes) as a humectant and 
thickener or as a sweetener. It occurs naturally in some fruits (especially in 
prunes) and berries. The caloric energy of sorbitol is 2.6 kcal (versus 4 kcal in 
sugar) and its sweetness has nearly 50% of the relative sweetness of sugar. The 
laxative effect of sorbitol (by drawing water into the large intestine and thereby 
stimulating bowel movement) is higher than with others polyols. 
The consumption history of sorbitol is long, its metabolism and side effects 
are well investigated, and therefore, it is known that absorbed sorbitol can be 
converted in a human body to glucose, but this process is not efficient. 
Unabsorbed parts can cause disturbances in the digestive tract. Because the 
absorption and metabolism of sorbitol in the human body are slow, the 
cariogenicity of sorbitol is lower than sugar, and sorbitol has sometimes been 




Xylitol, pentitol type 5-carbon polyol (C5H12O5), is naturally found in fruits and 
vegetables. Commercial xylitol is extracted from corn or birch wood or other 
xylan-containing plants. The sweetness of xylitol is like white, table sugar but 
the caloric value is 2.4 kcal/g compared to 4 kcal/g in sugar. The human body 
synthesises 5–15 g xylitol per day, where the xylitol is an intermediate product 
in carbohydrate metabolism in the clucoronate-xylulose cycle. The body does 
not require insulin to metabolise xylitol and therefore xylitol has been approved 
in special dietary foods, e.g. for diabetics. 
Xylitol has a long history – it has been used since the early 1970s. Xylitol, as 
a non-cariogenic and anti-cariogenic replacement for sugar, is popular in dietary 
products and in oral hygiene articles, especially in the US and in Finland. In the 
Turku Sugar Study (Scheinin and Mäkinen 1975), the potential of xylitol was 
thoroughly tested. In addition, numerous clinical trials have been carried out to 
investigate the effectiveness of xylitol. 
Repeated studies over 40 years (Sheinin et al. 1975, 1985, Kandelman and 
Gagnon 1990, Mäkinen et al. 1995) have confirmed the significant reduction of 
dental caries on several occasions, both in low- or high-risk groups. Xylitol has 
been used as a non-cariogenic sweetener, with the sweetness similar to sugar. 
The oral bacteria are generally not able to metabolize xylitol (metabolism is 
possible by some mutans streptococci species), and therefore, no acid 
production follows from the use of it. The study by Twetman et al. (2003) 
reported that lactic acid concentration reduced significantly in dental plaque 
after xylitol experience. The increased pH in dental plaque does not take place 
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and demineralisation is slower or non-existent. This could be one of the most 
important mechanisms of xylitol for caries prevention. 
Xylitol has also been used to reduce the quantity of dental plaque – it 
prevents the sticking of bacteria to teeth (Mouton et al. 1975, Söderling and 
Hietala-Lenkkeri 2010) although recent in vitro studies did not confirm this 
(Giertsen et al. 2011, Decker et al. 2014). Mäkinen et al. (1989) and Isokangas 
et al. (1991) have shown that xylitol is able to reduce the growth of mutans 
streptococci in the dental plaque, both after short- and long-term use. Thabuis et 
al. (2013) demonstrated a similar significant reduction of the growth of three 
other cariogenic species (S. sobrinus, Actinomyces viscosus and Lactobacillus) 
in dental plaque. This effect occurs through inhibiting Streptococcus mutans 
metabolism (Trahan 1995, Lingström et al. 1997). This was first discovered in 
in vitro studies (Knuuttila and Mäkinen in 1975) and since then, the mechanism 
has been repeated in several clinical trials (Miyasawa-Hori et al. 2006). 
In the majority of studies chewing gum containing xylitol has been used 
(Sheinin and Mäkinen 1976, Kandelman and Gagnon 1887, 1990, Wennerholm 
et al. 1994, Mäkinen et al. 1995, Thabuis et al. 2013, Keukenmeester et al. 
2014). Since chewing gum stimulates the secretion of saliva, which is a 
substantial factor in the process of pH neutralization, this could be an additional 
impact factor. However, xylitol can reduce dental plaque even in the form of 
candies (Alanen et al. 2000, Shyama et al. 2006). In addition to the preventive 
effect, xylitol has been found to promote tooth remineralisation. The inference 
has been based on the re-hardened caries lesions and negative caries lesions 
increment (Kandelman and Gagnon 1990). The recommended daily dosage for 
a caries preventive effect is 6–10 grams of xylitol (in different forms – chewing 
gum, tooth paste, mouthwash or candy), preferable regularly 5 times every day 
(Kandelman and Gagnon 1987), although studies using xylitol-sweetened 
chewing gum three times per day have shown Streptococcus mutans inhibitory 
effects (Autio 2002, Kiet et al. 2006, Holgerson et al. 2007). 
The long-term use of xylitol increases the portion of xylitol-resistant mutans 
streptococci, which lacks the fructose phosphotransferase system. This 
adaptation mechanism minimises the anti-cariogenic effect of xylitol but does 
not imply acidity (van Loveren 2004). Trahan (1995) has shown that the 
percentage of MS does not increase in dental plaque but increases in saliva. One 
feasible explanation given by Trahan et al. (1992) is more easily shed xylitol-




Erythritol is a tetritol, 4-carbon polyol (C4H10O4). It is the first industrially 
produced polyol from glucose using a fermentation process with yeast, Moniella 
pollinis. Erythritol occurs naturally in some fruits, algae, fungi, lichens and 
fermented foods. The relative sweetness of erythritol is 60–70% of that of table 
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sugar (sucrose). The cooling effect is close to xylitol –stronger than with the 
others alditols. The erythritol differs from others sugar alcohols, mostly because 
of its small molecular size and its unique digestion pathway. 
The first interest from the food industry was to use erythritol as a noncaloric 
bulk sweetener. The new trend among consumers towards natural components 
accepts erythritol, which is made naturally by fermentation and satisfies the 
food safety requirements. Erythritol is well tolerated in the gastrointestinal tract 
because of its property to be well absorbed (via passive diffusion) in the small 
intestine but not metabolized (fermented) in the body, and therefore, it is 
qualified as a non-caloric polyol. Erythritol has an estimated energy value near 
0, maximum 0.24 kcal/g (de Cock 1999, 2012, de Cock and Bechert 2002), and 
it has no effect on blood glucose and insulin levels. Excretion from the blood 
takes place through the kidneys (about 90%) and non-absorbed erythritol 
(~10%) that remains unchanged passes to the large intestine and is excreted 
with the faeces (Storey et al. 2007). This part of erythritol may be fermented by 
the microbiota of the colon. The laxative effect of erythritol is considerably 
smaller than after consuming others alditols because 90% is absorbed in the 
small intestine before moving to the large intestine. 
Erythritol has been shown (by Kawanabe et al 1992 and Mäkinen et al. 
2005) to be similar to xylitol in its dental plaque reducing effect. The 
mechanism of this effect has been examined for a shorter period and there are 
fewer studies about erythritol compared to alditols that have been in use for a 
longer period like sorbitol and xylitol. The in vitro experiment conducted by 
Kawanabe (1992) has shown that the species of streptococci do not produce 
either lactic nor other acids from erythritol. Similar test results have been shown 
by xylitol, but at the same time other widespread sugar alcohols indicated the 
same acid production. As reported by Söderling and Hietala-Lenkkari in 2010, 
streptococci were not able to grow and mostly not produce insoluble dextran in 
plaque from erythritol. 
 
*** 
In conclusion, both erythritol and xylitol have a clinical effect on caries 
prevention despite their biochemical mechanisms being different (Mäkinen et 
al. 2005).  
When designing the current study, there were no reports available on 
comparative long-term surveys of the impact of erythritol and xylitol 
consumption on dental caries development.  
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3. AIMS OF THE STUDY 
The general aim of the research was to evaluate the experience of caries among 
elementary school children and to test the impact of long-term polyol 
consumption on caries prevention. 
 
The purposes of this study were: 
1. To identify the prevalence of caries in permanent teeth and mixed dentition 
among first and the second grade schoolchildren in south-eastern Estonia. 
2. To determine the associations of the number of caries lesions between 
permanent and primary molars using ICDAS in the mixed dentition. 
3. To test and to compare the clinical effects of long-term intervention using 
polyols (erythritol, xylitol and sorbitol as a positive control) on the 
development of dental caries in mixed dentition. 
4.  To compare the effects of interventions using erythritol, xylitol and sorbitol 
on saliva and dental plaque. 
6
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4. SUBJECTS AND METHODS 
4.1. Selection of the schools and subjects 
The 3-year intervention study was a double-blind, randomized, placebo-
controlled prospective clinical trial. The study was conducted in south-eastern 
Estonia, where the level of fluorides in the drinking water is extremely low 
(near 0) and the DMFT index is the highest in Estonia (Ingel et al. 2010). The 
number of schools in this region, which includes 4 counties, was 102 in 2008, 
and the combined number of first and second grade pupils was 4,150 (Ingel et 
al. 2010). Schools stratified according to localisation and size were selected 
randomly from all municipal schools in this area (10%). One urban school, four 
regional centre schools, four rural schools and one elementary school, based on 
the proportional distribution, were selected. The invitation was sent via email. 
When the school refused (n=1) or did not respond (n=10), another school from 
the same strata (location, size of the school) was invited. The schools were not 
requested to state the reason for their refusal. 
When the management of the school agreed to participate in the study all the 
first and second grade children were included. Two to five first and second year 
classes per school were involved. The estimated sample size required for the 
three-year trial was 151 children in each intervention group where the expected 
drop out rate was 25%, according to the Belize study (Mäkinen et al. 1998). All 
first year classes in the schools were divided into three different study groups 
randomly using computer-generated numbers. The second year classes were 
distributed into different groups as appropriate to reduce a school bias.  
The written informed consent forms (n=522; Figure 1) were signed by the 
parents or guardians before the survey. The Research Ethics Committee of the 
University of Tartu approved the clinical trial (the study protocol 166/T-7). The 
clinical trial was registered with the US National Institute of Health register, 
identifier number NCT01062633. 
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4.2. Clinical examinations 
The clinical examinations were carried out in the Department of Stomatology 
(University of Tartu) at baseline and once a year (exactly at 12, 24 and 36 
months) during the trial. The examination included caries status registration, 
and plaque and saliva sample collection. Altogether, 485 children (45.6% boys 
and 54.4% girls) were observed in the standard dental units at baseline. The 
mean age of children in the first grade at baseline was 7.8 years (SD=0.35) and 
in the second grade 8.8 years (0.38). On the day of the examination 7.1% 
(n=37) of the children were absent. According to the teachers, the main reason 
for the absence was illness. 
The double-blind clinical examinations using ICDAS II criteria were 
completed by four examiners. The computer-based 90-minute e-learning 
programme, training and calibration which included examination, discussion 
and re-assessment of the same objects and inter- and intra-examinations of 
investigators were carried out two days before every annual examination. This 
process was guided by a senior clinical researcher. At first, eight children, not 
participating in the study, were examined by all of the four team members. All 
caries findings and disagreements were discussed and resolved after re-
assessment of the lesions. On the second day, 25 children were studied twice by 
one of the three examiners and by the senior examiner. During the study the 
scheduled 10 pupils were examined twice by each examiner and another 10 by 
the senior examiner. The inter- and intra-examiner consistency of the examiners 
was high (surface and tooth-based weighted kappa >0.9). 
 
4.2.1. Saliva sample collection 
The children were instructed not to brush their teeth on the morning of the 
examination day. The regular daily diet (breakfast and light lunch, if needed) 
was allowed. The pupils were blindly assigned to one of the four examiners. 
Dental plaque samples were taken for the Orion Diagnostica (Espoo, Finland) 
Site Strips Test from each quadrant by means of disposable Quick-Stick® 
microbrushes (Dentonova AB, Huddinge, Sweden) by gently rubbing and 
rotating near the gingiva between the teeth, from the interdental area of the 
mesial surface of the first permanent molars. 
Dental plaque – from all available, free surfaces of the teeth – was collected 
during three minutes using a dental probe. The plaque was immediately 
weighed, suspended in sterile 0.9% NaCl, frozen in dry ice and stored at –80 °C 
for further chemical analyses at a laboratory.  
The level of Streptococcus mutans (SM) and lactobacilli (LB) in the saliva 
were ascertained using industrially manufactured Dentocult® SM and 
Dentocult® LM test kits from the Orion Diagnostica company (Espoo, Finland) 
respectively. The tests were used to evaluate the counts of mutans streptococci 
(MS) in the saliva and in the (interdental) plaque of each quadrant and 
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aerobically cultured aciduric micro-organisms (mostly representing lactobacilli) 
from the saliva. 
To gather saliva streptococci, a spatula was rotated in a closed mouth 4–5 
times, touched the tongue and then gently removed through the subject’s gently 
closed lips. The interdental plaque and saliva sample spatulas were cultivated in 
the same tube according to the manufacturer’s prescriptions for two days (48 
hours at 37°C). The quantity of mutans streptococci and other acidogenic 
micro-organisms was valued by three investigators – scored 0, 1, 2 or 3, based 
on the manufacturer’s instructions – the guidelines from the Orion Diagnostica 
Dentocult® SM test. The mode of three examiners was used in the analyses. 
Scores 0 and 1 were <100,000 bacteria/ml saliva; score 3 was >1,000,000 
bacteria/ml saliva and score 2 was the parameter between the scores 1 and 3. 
Stimulated saliva, formed using paraffin, was collected while chewing a 
piece of paraffin (1.0 g) and the saliva flow rate – ml per minute – was 
measured. Some pupils were not able to follow the instruction during the saliva 
collection and sufficient volume of stimulated saliva for the LB test was then 
not collected. The same stimulated saliva from children was used for the LB 
tests (the Dentocult® LB). The slides were incubated for four days at 37°C. The 
number of lactobacilli and the other aciduric micro-organisms (the species was 
not distinguished) was counted by three people and scored 0, 3, 4, 5, or 6 per ml 
in the stimulated saliva, based on the manufacturer´s guidelines and a model 
chart, where zero marked no growth or a few colonies and six was abundant 
growth which covered the entire slide area. Again the mode of three 
assessments was used in the analyses. 
 
4.2.2. Caries recording 
Caries status was registered after the procedure described in the last paragraph 
and two-minutes of tooth brushing. All visible tooth surfaces in the mixed 
dentition were observed using a dental mirror and a standard light and 
compressed air from the dental unit. The blunt periodontal probe was used to 
detect any roughness of enamel surface. No radiographs were taken during the 
study. All restorations and caries lesions were recorded using the two-digit 
International Caries Detection and Assessment System (ICDAS II) where the 
first number denotes the restoration or sealant material and the second number 
shows the extent of cariotic lesions: early caries lesions in enamel (codes 1–3) 
and dentinal caries lesions (codes 4–6), maximum 28 teeth and 128 tooth 
surfaces. 
A caries code 0 represents a sound, healthy tooth surface, free from any 
caries defects. The codes 1 and 2 mark the first visual changes in the enamel: 2 
provided the lesion is seen immediately on the wet tooth surface during the 
examination and 1 if the white spot lesion is visible only after 5 seconds of 
drying with compressed air from the dental unit equipment. Code 3 denotes 
superficial defect, localised in the enamel – no dentine is visible. If the defect is 
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shown as a grey or darker shadow under the intact enamel (without cavitation 
into dentine) it would be marked as code 4. Both 5 and 6 indicate a caries lesion 
in the dentine: 5 if the distinct cavity is confined to less than half of the 
corresponding tooth surface and 6 when the bulk of the dentine of the surface 
involves caries. 
No treatment procedures were carried out during the clinical examination. 
The written information about the need for restorative or orthodontic treatment 
was given to the parents. Oral health and diet education for participants took 
place in a lecture hall every year during the investigation. The basic 
recommendation was to brush teeth twice a day. A toothbrush and fluoride 
toothpaste (with 0.24% sodium fluoride) were given to all children twice a year. 
 
 
4.3. Polyols consumption 
All classes were randomly allocated (detailed description above) into three 
intervention groups – sorbitol (n=164), xylitol (n=156) and erythritol (n=165) 
group. The number of children dropped during the clinical trial (see Figure 1). 
The polyols were in the form of hard lozenges, designed for sucking and 
manufactured for this study by Cargill R&D Centre Europe. The weight of the 
candies was around 0.7 g and ~90% contained sorbitol, xylitol, or erythritol. 
Each polyol was consumed three times per day − four candies at a time, 12 
daily − in the morning before the beginning of the first lesson, after school 
lunch (before noon) and at the end of the school day, immediately before 
leaving school. The candies were distributed and supervised by the class 
teachers. Daily polyol intake was about 7.5 g for around 200 school days per 
year. 
Annual site-visits by the investigators took place during the study to control 
the storage of the polyols in schools and observe how the consumption of the 
candies was organised. A presentation was delivered in classrooms to enhance 
the motivation and awareness of the participants. 
 
 
4.4. Chemical procedures 
The fresh dental plaque samples, collected using a probe and placed in a 
disposable weighing cup at the time of the clinical examination within 3 
minutes from all free tooth surfaces of the children, were instantly weighed on 
the analytical scales and dissolved in sterile physiological saline (0.9% NaCl) in 
an iced water bath. The plaque samples of the fixed group, ten plaque samples 
in a pool at baseline, were combined for HPLC-based analyses. In later years, 
the same ten subjects were part of the same collection process or if a child was 
absent during re-examination, the number of samples in the pool was smaller. 
The specimens from the pools were frozen in dry ice and stored at –80°C 
and transported to the Cargill laboratory (Vilvoorde, Belgium) for chemical 
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analyses, where the concentration of plaque sugars, organic acids (acetic, 
propionic and lactic acid) and polyols was assessed using HPLC. 
 
 
4.5. Data analyses 
The final study groups for statistical analyses consisted of 485 pupils for 
epidemiological studies (Original Papers I and II) and of 374 children to 
investigate the impact of polyols (Papers III and IV). 
All data were entered into an Excel table and were analysed using SPSS 
(version 18.0 and 19.0; SPSS Inc., Chicago, IL, USA) and/or using the SAS 
System for Windows (9.2 or higher; SAS Institute Inc., Cary, NC, USA). All 
the main statistical analyses were conducted at ClinData Services (Turku, 
Finland) by Tero Vahlberg (responsible statistician). 
The ICDAS II caries codes were converted into DMFT indices for statistical 
analyses to produce descriptive epidemiological data. To assess the changes in 
caries lesions through the follow up, the ICADS II codes were used. The 
dynamics of the carious process was evaluated only on those 374 participants 
who were examined each year during the trial – on baseline and subsequently 
every year (four times in total) – those data were included to analyse the clinical 
caries preventive effect of polyols. The following surfaces and teeth were 
excluded from the analysis because in these cases it was not possible to follow 
the dynamics of caries: extracted teeth which during a previous examination 
were recorded as having dentinal caries, surfaces which were restored by a 
dentist before an investigation, and occlusal surfaces with partial or full sealants 
(restoration codes 1 and 2). 
The scoring procedures for mutans streptococci and lactobacilli have been 
described above. The mode of the scores for mutans streptococci and 
lactobacilli, assessed by three investigators, was taken. 
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5. RESULTS 
5.1. Caries experience in permanent teeth  
(baseline data) 
At 7–9 years the first permanent molars have erupted and deciduous incisors 
replaced with permanent ones. The exfoliation time of primary molars (and 
canines) is commonly between 9 and 12 years. The permanent premolars rarely 
erupt in the first school years, except in cases of early loss where the primary 
molars have been extracted before physiological exfoliation because of pulpal 
infections. In that case the permanent premolars can replace the extracted 
deciduous molars earlier than happens normally. 
In the case of the upper incisors, when recently erupted, even enamel caries 
damage was rare. In this case the proximal, labial and/or palatal surfaces of all 
upper incisors were involved. Only a couple of white spot lesions on the lower 
incisors were found during the examination. 
The permanent molars appear to the end of the tooth arch at the age of 6 
without any replacement of teeth and can remain unnoticed by parents who 
believe them to be primary teeth. The first permanent molars were the most 
affected teeth in the permanent dentition. According to the data from the 
examination (Paper I, Table 3), caries damage was found mainly in fissures 
(occlusal surfaces, buccal fissures in the lower and palatal fissures in the upper 
molars). Restorative treatment of dental decay had been carried out in 10.9% of 
the upper molars (teeth 16 and 26) and in 21.0% of the lower molars (36 and 
46). The number of sealants was lower than expected, only 2.4% among the 
first graders’ and 3.9% among the second grade children’s fissures of the first 
permanent molars, which were partially or totally covered by sealants to prevent 
occlusal caries. 
Caries was recorded annually during the investigation using the ICDAS II 
coding system separated as early stage caries lesions or caries defects in the 
enamel (ICDAS II codes 1–3) and dentinal caries – codes 4–6 as caries in the 
dentine is equal to the D (decay) component of the DMFT index. Enamel caries 
lesions are not considered for the DMFT index. The prevalence of caries – the 
proportion of children with D4–6MFT>0 – in permanent dentition was 36.2% 
among first grade pupils and 48.3% among second grade pupils. 
Most caries indices in permanent dentition were predominantly higher 
among the older, the second grade children, The mean D4–6MFT indices were 
0.8 (SE=0.11) among the first graders and 1.1 (0.10) among the second graders 
(Figure 2). The mean D4–6MFS (caries or its treatment or complication by 
surface) indices coincided, respectively 1.6 (0.31) and 1.6 (0.17). There were no 
statistically significant differences in the caries experience between the genders 
in the mean caries indices: DMFT and DMFS indices, D1–3T, D1–3S (enamel 




Figure 2. Mean caries indices (enamel and dentine) by grade 
 
The mean number of enamel caries lesions (D1–3T and D1–3S) and restorations 
(FT and FS) were significantly lower for the first graders than the second 
graders. The mean of enamel caries lesions by tooth (D1–3T) in first graders was 
1.6 (0.10) and the mean number of enamel caries lesions by surface, (D1–3S) 2.2 
(0.16). Among second graders, the same figures were respectively 2.1 (0.11) 
and 3.0 (0.18). At the same time, there was no statistically significant difference 
between the grades in the number of dentinal caries lesions: the mean D4–6T in 
both groups was 0.2 (SE=0.06/0.03). The D4–6S (dentinal caries by surface) for 
first grader children was 0.4 (0.12) and among second graders 0.2 (0.04). 
 
 
5.2. ICDAS II codes in mixed dentition 
During the trials all caries lesions were registered according to the ICDAS II 
two-digit system. 
Teeth are more susceptible to damage immediately after eruption, generally 
during the first year in the mouth. Therefore, it was expected to find that caries 
lesions were more prevalent in the early stage (ICDAS II codes 1–3) in 
permanent molars, mainly on the occlusal surfaces of both lower and upper 
permanent molars but also on the buccal surfaces of the lower molars (Table 2). 
The teeth most affected by dentinal caries (codes 4–6) were predominantly the 







Table 2. The mean percentages of ICDAS codes in the upper and lower first permanent 
molars and second primary molars according to tooth surfaces 
 ICDAS codes  ICDAS codes 
 0 1 2 3 4 5 6  0 1 2 3 4 5 6 
16/26        36/46        
M 97.7 0.3 0.4 0.3 0.0 0.2 0.0 M 94.6 0.3 3.6 0.4 0.0 0.2 0.2 
O 62.5 12.4 17.0 4.8 0.8 1.4 0.0 O 68.8 7.5 13.6 6.4 1.1 1.5 0.3 
D 99.0 0.0 0.0 0.0 0.0 0.0 0.0 D 99.1 0.0 0.0 0.1 0.0 0.0 0.1 
B 91.5 2.2 4.8 0.3 0.0 0.1 0.0 B 64.5 9,4 16.3 7.3 0.6 0.9 0.2 
L 83.4 4.7 9.0 1.0 0.3 0.5 0.0 L 97.3 0.5 1.3 0.0 0.0 0.0 0.1 
55/65     75/85    
M 81.8 0.4 1.5 1.0 1.4 4.3 5.4 M 72.9 0.9 5.0 3.0 0.5 3.7 5.6 
O 69.4 5.1 10.2 3.5 1.0 2.9 2.3 O 66.6 4.1 8.9 3.5 1.0 2.2 5.3 
D 93.4 0.1 0.1 0.7 0.3 1.2 4.0 D 82.9 0.3 1.0 0.0 0.0 1.2 6.0 
B 90.9 0.6 1.4 0.3 0.1 0.4 2.1 B 68.0 3,3 13.1 2.0 0.1 0.5 3.5 
L 83.9 2.2 3.1 2.1 0.5 0.8 3.3 L 85.0 0.2 0.8 0.1 0.1 0.4 4.9 
 
The most common finding was code 2 – first visible changes on the wet tooth 
surface in the enamel, when the dentine was not yet involved – in fissures on 
the occlusal surfaces of the upper permanent molars (17.0%) and on the buccal 
(16.3%) and occlusal (13.6%) surfaces of lower permanent molars. Codes 2, 3 
(defects still only in the enamel), and 5 (limited visible lesion through the 
enamel in the dentin) per child dominated in their mixed dentition, while code 4 
(shadow under enamel) was the least recorded. The highest mean number of 
affected surfaces per child were ICDAS II codes 2 (2.67) and 6 (extensive 
cavitation into the dentine; 1.96), and the lowest once again code 4 (0.68). 
The distribution of ICDAS II codes between the first permanent molars and 
the second primary molars showed a significant correlation on the lingual 
surfaces of the upper molars and on the buccal surfaces of the lower molars 
(Paper II, Table 3). 
The codes in mixed dentition by age and by grades varied (Paper II, Table 4) 
and were less informative because of physiological exfoliation and extractions 
of primary molars, which were extensively damaged by caries. 
 
 
5.3. Clinical effects of erythritol and  
xylitol on caries prevention 
At the start of the study, the mean age of the children in the erythritol group was 
8.6 years (SD=0.5). In other groups the age was lower, 8.2 (0.5) in the xylitol 
and 8.1 (0.6) years in the control (sorbitol) groups (p<0.001). The percentage of 
boys was a slightly higher in all study groups: 57.0% in the erythritol, 54.5% in 
the xylitol and 51.8% in the control group (p=0.645). 
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There were no differences between the study groups in terms of basic caries 
indicators in their mixed dentition before the intervention, at the baseline. After 
one year of alditols consumption, the main caries indices were not statistically 
significantly different. In the second year of the study the numbers and 
percentage of teeth (Dd4–6Tt) and surfaces (Dd4–6Ss) with dentinal caries in 
mixed dentition were lower in the erythritol intervention group than in the 
xylitol group: Relative Risk (RR) for caries was 1.96, (95% CI 1.24–3.10) and 
2.33 (95% CI 1.37–3.98), respectively. Similar changes were found in the third 
year when there was a higher number of dentinal caries on tooth surfaces (Dd4–
6Ss) (RR=1.93, 95% CI 1.12–3.33) in the xylitol group. 
The development time of the caries lesions (both caries in enamel and dentin) 
was considerably slower over the three years (p<0.001) in the erythritol group 
than in the other groups (Paper III, Figure 2). The cariotic process affected 4.6% 
of the tooth surfaces of the erythritol group against 5.8% in the xylitol group 
and 5.5% in the sorbitol group (Table 3). At the same time, there were no 
statistically significant differences between the groups analysed by gender, age 
or school. 
 
Table 3. Number and percentage of surfaces according to the analysis of caries 
development 











































0.415 0.682 0.385 
aχ2 test. b Fisher’s exact test (two-tailed). 
 
Looking at the data separately, there were less tooth surfaces with enamel caries 
that had developed into dentinal caries within three years in the erythritol group 
(1.3%) than in the other groups. The percentage of caries lesions extending to 
dentin was noticeably higher (p=0.003) in the xylitol (2.0%) and in the sorbitol 
(1.7%) groups (Paper III, Table 4). The results were similar in respect to the 
time it took for the caries process to extend into the dentin – it was significantly 
longer in the erythritol group compared to the other (xylitol and sorbitol) groups 
(p=0.009; Paper III, Figure 3). During the intervention caries risk was higher 
among the xylitol and sorbitol groups, younger children and among boys than 
among erythritol groups, older children and girls. 
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A decrease in all caries codes over the trial took place in all study groups 
(28.3–30.5%; Paper III, Table 4) and was markedly lower (p=0.006) according 




5.4. Salivary and plaque indicators 
5.4.1. Salivary SM and LB levels 
At baseline there were no differences in LB or SM levels in saliva or dental 
plaque between the study groups. Statistically significant differences occurred 
during the third year in the SM scores. The SM counts in saliva and in plaque 
on the upper teeth were significantly higher in the sorbitol (as a control) group 
compared to the erythritol group (p<0.05). Both positive intervention (erythritol 
and xylitol) groups had statistically significant differences (p<0.01) within the 
groups (except in LB counts), where xylitol did not reduce the SM level. 
 
5.4.2. Salivary flow rate 
The stimulated salivary volume was measured during each examination. As 
expected, the volume increased (p<0.01) in all groups because the children were 
growing. The mean rates were 1.1 ml/min at baseline, 1.5, 1.8 and 2.0 ml/min 
respectively in the first, the second and the third year. No differences were 
found between the groups during the study. 
 
5.4.3. Plaque weight 
There were no significant differences in the weight of the fresh, just collected 
plaque between the groups at baseline. The lowest values and reduction of 
collected plaque were seen during the trial in the erythritol group (p<0.05). In 
the other (sorbitol and xylitol) groups no changes were observed during the 




Figure 3. The reduction of mean plaque fresh weights during intervention, compared 
with baseline values 
 
5.4.4. Chemical analyses of plaque 
The concentration of acetic, propionic and lactic acids were calculated within 
the clinical trial. The lowest findings were registered after the third year in the 
erythritol group. The statistically significant (p≤0.05), detectable reduction of 
acetic and propionic acids were observed among all study groups. Any 
statistically significant differences were not recorded during the clinical study in 
the xylitol group. 
The concentration of erythritol and xylitol did not differ between groups in 
any of the years. The sorbitol level in individual plaque varied from 0 to 700 µg 





6.1. Methodological consideration 
The study consisted of two elements: the first part was an epidemiological study 
among elementary school level children (Original papers I and II), and the 
second, an evaluation of the clinical effect of the long-term consumption of 
polyols on caries prevention in mixed dentition (Papers III and IV). 
This survey was the first long-term clinical trial to compare the role of 
different polyols in caries prevention. The randomly selected investigation 
group covered around 10% of all schools and schoolchildren in this region, and 
provides reliable information about caries prevalence and experience. The size 
of the study groups was sufficient to get statistically significant results. The co-
operation with the schools, teachers and children was good throughout the 
study. 
 
6.1.1. Study subjects 
Participants were from randomly selected schools in south-eastern Estonia. The 
initial number of returned written agreements, signed by parents or guardians, 
was larger (n=522) than expected but the final size of the groups (n=485) was 
formatted by the baseline examination; respectively 164 in the sorbitol group, 
156 in the xylitol group, and 165 in the erythritol group, which was close to the 
planned 151 children for each group. The predicted percentage of participant 
dropout was 25% over the three years; however, the actual decrease was lower 
(mean of 22.9%), being higher in the erythritol group (26.6%) and lower in the 
sorbitol group (23.2%), and in the xylitol group (19.2%). The main reason for 
the absences during the examination was illness and the main reason of 
interruptions to the study was children changing their place of residence and 
school (reported by the class teachers). 
 
6.1.2. Study design 
The hypothesis of the clinical trial was that erythritol and xylitol would have a 
similar effect, as previously shown from a 6-month study (Mäkinen et al. 2005). 
This study was the first randomized clinical trial where the efficacy of 
erythritol and xylitol in caries prevention were compared with sorbitol during 
long-term daily intake. At the same time it was the longest follow up study of 
erythritol consumption. The study was carried out over four years: a baseline 
examination and three-year polyols consumption with annual examinations. 
All children were examined annually at the university clinic by four 
investigators. The clinical examinations took place once a year during one week 
at the same time each year. The sequence of classes and the timetable were 
(with small changes) the same for each examination. The purpose of keeping 
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the timeframe was to minimize the differences of the chemical ingredients in 
the dental plaque, which could have been the result of time differences between 
the meal/polyols candies consumption and taking plaque samples. 
Responsible teachers were remunerated for extra work, which consisted of 
daily candy distribution and monitoring. The clinical examinations were also 
combined with bonuses (free transport and visits to museums) and gifts (free 
fluoridated toothpaste and a toothbrush twice a year) for children, which 
probably motivated and ensured lasting participation. 
The supervision of polyols consumption in schools was organized on-site by 
the class teachers. The annual site-visits confirmed that the products were being 
stored appropriately as described by the manufacturer, and the consumption of 
polyols on schooldays was managed as required by the study design. Verbal 
communication with the teachers confirmed the children’s good tolerance of 
polyols intake. The motivation among the participants was high, and throughout 
the trial all newcomers were included in the study via a signed consent form by 
their parent/guardian. 
 
6.1.3. ICDAS II coding system in clinical examination 
Caries findings were recorded using the new ICDAS II system, described by 
Ismail et al. (2007) and Pitts et al. (2009). The calibration was carried out 
following the instructions of the developers of this system. The ICDAS II caries 
recording system needs thorough training. The 90-minute e-learning programme 
is available on the web for self-instruction and even an experienced person that 
has used this system before is recommended to investigate the programme 
before the trial and for calibration. 
Even though the reliability of the inter- and intra-examiners during the 
calibration of examiners was very high (Cicchetti and Allisson, 1971; the 
weighted kappa was >0.9), each child was examined and dental plaque was 
collected by the same examiner each time in order to reduce possible variation 
due to human factors. A good light (of the dental unit) and clean, dry teeth are 
obligatory for adequate caries detection. Proximal caries diagnosis was 
questionable at later ages in permanent dentition, where in case of doubt 
additional radiographic diagnosing is necessary. In our study, the average time 
per child for registering their dental status was around 3…5 minutes, depending 
mainly on the number of cariotic lesions, although Braga et al. (2009) reports 
that an examination using the ICDAS II system takes twice as long as DMFT 
index recording according to WHO criteria. 
The visual assessment of caries is well tolerated even in younger children 
and caused less discomfort compared with other caries diagnostic methods 
(Novaes et al. 2012). In our study only a couple of children refused the dental 
examination at such an early age because of dental anxiety. At the same time, 
they were not afraid of the saliva tests, which were taken. 
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The main difference between the DMFT index, which has been used as the 
main epidemiological caries indicator for more than 70 years, and the newer 
ICDAS II system is the registration of caries at an early stage. It gives the 
opportunity to monitor the evolution of caries lesions during the clinical 
investigation study. The ability to convert recorded caries codes from ICDAS II 
for entry in the DMFT index has been approved in recent studies (Iranzo-Cortes 
et al. 2013, de Amorim et al. 2012) with some difficulties in classifying codes 3 
and 4 as concluded in a review of the literature (Clara et al. 2012). Thorough 
calibration and following the guidelines of the ICDAS Committee provides 
reliable recorded data. 
 
 
6.2. Dental caries 
During the 1990s, the DMFT indices among 12-years-olds in Estonia decreased 
rapidly from 4.1 in 1992 to 2.7 in 1998, according to the electronic Oral Health 
Database (2007). The reason for this could be the re-establishment of 
independence in Estonia when the transition from the socialist system to the 
capitalist system was taking place. People’s attitude to oral hygiene and healthy 
teeth changed – healthy teeth and a bright smile became a characteristic sign of 
a higher social and economic status. The open borders made access to 
fluoridated toothpaste possible, which is an important factor in caries 
prevention. 
The mean DMFT among 12-year-olds is still higher in Latvia (3.4 in 2004) 
and in Lithuania (3.7 in 2005; Oral Health Database 2007) than in Estonia. In 
Nordic countries the national programmes for caries prevention have led to a 
significant rapid decrease in caries. In Finland DMFT among 12-year-olds 
declined from 6.9 in 1975 to 0.7 in 2009, in Denmark from 5.2 in 1975 to 0.6 in 
2012, and in Sweden from 6.3 in 1977 to 0.8 in 2011. The caries risk among the 
same age Estonian schoolchildren is moderate – the mean DMFT in Estonia is 
near the European average (2.6). Earlier studies have shown high caries indices 
(up to 5.1 in Võrumaa and up to 5.6 in Põlvamaa) in the south-eastern region 
versus the Estonian average (2.7) among 12-year-olds. The expectation before 
the baseline data collection was high caries scores among the younger group (7–
8-year-olds). 
In our study the DMFT+dmft indices in mixed dentition were higher at the 
baseline and lower later because of the normal exfoliation of primary teeth. The 
most damaged teeth were primary molars, and for the fourth and fifth grades, 
the extensive foliation process of primary molars was taking place producing 






6.3. Prevention of caries 
6.3.1. Professional procedures 
The high caries indices in south-eastern Estonia clearly demonstrate the need 
for caries prevention in this region, but the obtained data showed low 
prevalence of fissure sealants in elementary level schoolchildren in the present 
study. The official guideline on caries prevention in children – prepared by 
order of the Health Insurance Fund of Estonia – provides professional directions 
for dentists and includes methods like local fluoride application after every 6 
months and covering fissures and pits in primary and/or permanent molars with 
sealants if an individual need for this has been assessed. In this study, the 
written information about treatment need and verbal instructions for the proper 
oral hygiene and dietary recommendations were given to pupils, but no 
prescription for professional prevention procedures. Subsequent contact with 
the child’s dentist for treatment was voluntary and the child or his/her guardian 
could refuse or ignore those directions. Based on the study by Olak et al. 
(2013), children from low-income families probably stayed away because of 
low motivation of oral health and/or dental anxiety. 
During annual examinations in the Department of Dentistry at the University 
of Tartu, children attended courses on oral health education, including brushing 
instruction and diet recommendations. 
 
6.3.2. Fluorides 
All children were equipped with 0.24% sodium fluoride toothpaste – one tube 
was given biannually, after every 6 months – during the trial and, furthermore, 
they were instructed to brush their teeth with this twice a day, which would 
ensure the required daily dose of topical fluorides on the prevention of caries. 
The fluoride level in the drinking water in Estonia varies greatly. The level of 
fluorides in the groundwater in this area has been reported to be lower than the 
Estonian average. Some randomly selected schools were located in territories 
where the fluoride level was optimal (from 0.8 to 1.2 mg/L) or even higher (one 
school in Tartu where the concentration of fluorides in tap water was over 
1.2 mg/L).  
Additional analyses of data on the basis of the level of fluorides in the water 
supply (<0.5 versus >0.8 mg/L) showed statistically significant differences in 
the occurrence of caries lesions. In areas, including south Estonia, where the 
level of fluorides in drinking water is below optimal (<0.5mg/L), preventive 








6.3.3. Effect of polyols 
DMF indices in mixed dentition decreased throughout the trial because of the 
physiological exfoliation of primary teeth, especially in deciduous molars, 
which were the most affected teeth in the mouth according to assessments at the 
baseline. In order to minimize this effect, only teeth which were registered 




The most unexpected outcome of the trial was that no differences were detected 
between the xylitol group (as an intervention) and the sorbitol group (which was 
the control). The majority of studies have demonstrated the priority of xylitol, 
and the lack of any effect during the study is difficult to explain. One of the 
most possible reasons could be a discrepancy in dosing frequency and intervals. 
The recommendation to achieve the maximum effect for caries prevention is to 
distribute portions of xylitol evenly throughout the whole day (Kandelman and 
Gagnon 1987, 1990, Söderling 2009). Schooldays at elementary school level are 
short and could have already ended at noon for the first grades and around 3 pm 
in the higher grades. Therefore, the use of the test items was limited to a 
relatively short period of about 5 hours considering the recommendation that 
xylitol should ideally be used throughout the day. There were only three 
exposures per day, which is definitely too few. Unfortunately, the need for the 
controlled intake of polyols could not allow the self-consumption of polyols 
later, at home. Therefore, the consumption did not cover the whole day and the 
weekends and school holidays (around 150 days in total). Consequently, the 
intervals between the last dosage and the first dosage of the following day were 
longer than required and this could reduce the anticipated positive effect of 
xylitol. 
On the other hand, xylitol has shown the prolonged caries prevention effect 
to be significantly higher when xylitol has been used for a couple of years 
immediately after tooth eruption (Hujoel et al. 1999, Hayes 2001). So we could 
have the expected similar effect in the mixed dentition in the present study as 
well. 
The second explanation of the inconsistency could be a fact which appeared 
during the personal conversation with teachers at the time of site visits in the 
schools. Teachers were instructed not to force children, so when children 
occasionally complained about the excess of sweets (it was not possible to 
designate the type of polyols because of the double-blind study design), 
teachers suggested children take less polyols lozenges than suggested. 
Therefore, the daily dose was low. The consumption was also omitted when the 
pupils were ill. The tolerance of the taste of polyols during the study was not 
asked, but some children complained about the taste of the product, and this 
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would have required additional investigation. One possible solution to reduce 
the sweetness of polyols could be a mixed combination of polyols, but another 
similar long-term trial has recently been carried out where xylitol and erythritol, 
both in combination with maltitol were tested (Lenkkeri et al. 2012), during 
which no caries-preventive effects were discovered. 
 
6.3.3.2. Erythritol 
The main finding of this study of long-term polyols consumption was lower 
incidence of caries lesions in dentin by tooth and surface in mixed dentition in 
the erythritol group compared with the xylitol and sorbitol groups. The first 
statistically significant differences between the groups were recorded at 24 and 
36 months of polyols intake. No differences were recognized at 12 months – 
this is an anticipated outcome because caries formation is a dynamic process 
with multiple de- and remineralisation cycles, which can be stopped, and caries 
development from superficial damage to visible cariotic cavities takes some 
years. Warren et al. (2006) reported that about 30% of white spot lesions of 
fissures in primary (and later in mixed) dentition progressed to cavities during 
four years. On the smooth surfaces (e.g. near the gingiva), these figures are even 
lower – only 5% of all demineralised enamel lesions were filled after four years. 
 
6.3.3.3. Supplemental impact 
Most xylitol studies have used xylitol in the form of a chewing gum (see 
literature review by Mäkinen, 2010), which have accompanied the effect of 
chewing, and thereby, increased saliva production as an additional preventive 
factor. Only a couple of studies have used polyols in other forms (Honkala et al. 
2006, Taipale et al. 2007, Milgrom et al. 2009). Duane (2011) and Lenkkeri et 
al. (2012) reported the use of polyols in combination in the form of lozenges, 
and there were no statistically significant differences on caries prevention. In a 
systematic review of non-chewable xylitol candies and lozenges, Antonio et al. 
(2011) concluded that although an overall reduction of caries took place, the 
effect was higher on the free surfaces and was not expressed on the closed, 
proximal surfaces. 
One important explanation could be annually delivered dietary and tooth 
cleaning instructions to the participants. Cooper et al (2013), in their systematic 
review, could not find sufficient evidence of improvements from the same 
habits during school-based behavioural intervention among children aged 4–12 
years. In our study, an extremely low amount of new caries lesions occurred 
during the intervention in all study groups, which could be credited to improved 
oral hygiene and the overall reduction of sugar consumption between meals. 
This was obviously due to the increased attention drawn towards dental health 
by the teachers, parents and examiners. 
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6.4. Saliva and plaque parameters 
6.4.1. Bacterial content 
The thickness and bacterial content of dental plaque have a strong correlation 
with dental caries. The thicker layer of plaque includes a potentially higher 
number of cariogenic bacteria which are able to rapidly metabolize dietary 
carbohydrates into acid (Kashket et al. 1996). The neutralizing of this pH 
decrease, caused by acidic excretes of bacteria in plaque, may be hindered and 
slowed if the plaque contains voluminous mass. 
Biological studies have shown that erythritol could have a similar effect to 
xylitol, and therefore, may influence plaque quantity, adherence, and the growth 
of streptococci in dental plaque. In our study, all biological parameters 
associated with caries development – plaque weight and MS counts in salivary 
and in plaque, all assigned during the present clinical trial – were ultimately 
lower in the erythritol group compared to the xylitol and sorbitol groups. This 
result is compatible with the lower dentinal caries numbers in the erythritol 
group in the present study and with earlier short-term trials (Mäkinen et al. 
2001, 2005), which also demonstrated reduced levels of MS in saliva and in 
dental plaque. 
The majority of biological studies have shown clear distinctive differences 
between xylitol and sorbitol containing products where xylitol had reduced the 
amount of plaque and inhibited the growth of MS on the tooth surfaces. The 
latter is also reflected in the SM level of saliva. The expected positive effect on 
caries prevention in the xylitol group was not confirmed in this study. 
The overall LB level in the present case was relatively high, which coincided 
with the previous study, where a high level of LB in saliva was reported by 
Kõll-Klais et al. (2004). At the same time, there was no statistical difference in 
the LB counts between the study groups, although the long-term programmes 
with xylitol chewing gum in schools in Belize and China demonstrated salivary 
LB reduction (Mäkinen et al. 1995, 1996, 2008). The overall level of teeth with 
dentinal caries among pupils was relatively low during the trial and this may be 
reflected in the stability of the LB counts. 
 
6.4.2. Chemical properties 
The growth of aciduric organisms accelerates during the metabolism of dietary 
carbohydrates, and the replacement of sugars with polyols should decrease the 
growth of this type of microbiota. In our study, the reduction of organic acids, 
which were measured in dental plaque during the trail as surrogate markers of 
caries – acetic acid, propionic acid and lactic acid – occurred only in the 
erythritol group. One historical research (Carr and Krantz 1945) has shown that 
acetic acid bacteria do not metabolize erythritol, and the same could 
characterize lactic acid bacteria. 
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As it was presented in the results, the sorbitol level in plaque varied 
markedly between subjects and increased throughout the study. During the 
clinical trial there was no opportunity to eliminate all other polyols except the 
intervention substance. Sorbitol is an especially common sweetener in ordinary 
food, sweets and also in toothpastes, which were given to the children during 
the present study. We can speculate at the role other polyols consumed at the 
same time may have played. The answers may be found from studies, which test 
polyols in a mixed form. 
The success of erythritol may be concealed in the differences of the physical 
properties between the polyols. Erythritol as a four-carbon tetritol type polyol 
has a smaller molar mass (122.1 g/mol) compared with xylitol (152.1 g/mol) 





1. The prevalence and experience of caries among elementary school children 
in south-eastern Estonia is high, which matches previous studies. The 
prevalence increases rapidly in this age group – there is a statistically 
significant difference between first and the second graders. This age group 
needs intensive caries prevention programmes. 
2. ICDAS recording gives appropriate information about the occurrence of 
caries lesions. Untreated caries lesions in mixed dentition increase caries risk 
for permanent teeth. 
3. Lower second primary molars and the first permanent molars are the most 
frequently affected teeth in mixed dentition. The first molars are the first 
affected permanent teeth. Dental caries starts in fissures, predominantly 
shortly after the eruption of the teeth which may be prevented using sealants, 
but the number of sealants among the examined children is extremely low. 
4. Erythritol demonstrates a delaying of caries − caries progress was slower in 
the erythritol group compared to the sorbitol and xylitol groups and the 
effect was apparent after 2 years of erythritol lozenge consumption. We can 
conclude that erythritol is a well tolerated sweetener which has high 
potential in caries reduction. 
5. Erythritol consistently reduces the amount of dental plaque, the levels of 
acids in dental plaque and the counts of Streptococcus mutans compared 
with sorbitol and xylitol lozenges. Therefore, erythritol is effective in caries 
prevention through controlling plaque quality and quantity. 
6. As previous studies have proven the caries decreasing effect of xylitol, the 
modest role of xylitol in this study is difficult to explain. One probable 
explanation could be insufficient consumption per day – 3 times per day 
against 4–5, which has been generally recommended. The regular, daily 
intake of polyols is recommended. 
Based on the results obtained, erythritol based lozenges could be 
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SUMMARY IN ESTONIAN 
Suutervis algklasside õpilastel ning polüoolide  
toime hambakaariese ennetusele 
Sissejuhatus 
Kaaries on multifaktoriaalne haigus, mille peamised määrajad on atsidogeensete 
bakterite olemasolu ja hulk, eelnevate kaariese kahjustuste esinemine, süsi-
vesikute osakaal toidus ja nende tarvitamise sagedus, fluoriidide tarbimine, sülje 
hulk, sotsiaalne staatus jpm tegurid.. Suuõõnes on leitud sadu erinevat liiki 
mikroorganismi ja osa neist kuulub püsikooslusesse. Hambakaariese tekkega 
seostatakse eeskätt streptokokkide perekonda kuuluvaid baktereid, millest tun-
tuimad on Streptococcus mutans ja S. sobrinus. Kaaries algab hamba pinnalt 
laigu staadiumis kahjustusena kui emailist on talle tugevust andvad mineraalid 
(kaltsiumi ja fosfori ioonid) bakterite happeliste ainevahetusjääkide toimel välja 
lahustunud, samas toidukordade vahel ladestuvad mineraalid süljest hamba-
pinda tagasi. Selline protsess, millega kaasneb emaili ja dentiini destruktsioon, 
on pidev. 
Hambaemaili remineraliseerumist soodustab fluoriidide olemasolu joogi-
vees, mis on Eesti erinevates piirkondades väga kõikuv, varieerudes 0 mg/l 
Kagu-Eestis kuni varasemalt kohati 5–7 mg/l Lääne-Eestis (Indermitte jt 2009, 
2014). Kagu-Eesti kõrgemaid kaariese näitajaid seostataksegi fluoriidide vähe-
susega joogivees. Tänapäevased teooriad tunnustavad suhkrute osa kaariese 
tekkes ja seetõttu on oluline leida alternatiivseid magusaineid, mis oleksid 
vähem kariogeensed. Selliseks süsivesikute rühmaks on suhkuralkoholid ehk 
polüoolid millede metabolism suuõõnebakterite poolt on aeglasem kui 
suhkrutel. Tuntuimaks esindajaks on ksülitool, mida on uuritud aastakümneid ja 
mille kaariest ennetav efekt on korduvates katsetes tõestust leidnud. Soomes 
kuulub ksülitool riiklikult reguleeritud kaariese ennetuse programmi. Uuematest 
ainetest on esile kerkinud erütritool, mis testituna lühiajalistes katsetes on 
andnud ksülitooliga sarnaselt häid tulemusi kaariese ennetuses vaatamata nende 
erinevale toimemehhanismile. Polüoolide ehk suhkuralkoholide regulaarne 
kasutamine on näidustatud eelkõige riskirühmadel – lastel ajal, mil hambad on 
kergemini kahjustatavad (umbes aasta jooksul peale lõikumist) ja kaariese riski 
vähendamiseks toidukordade vahepalades ning maiustustes. 
Kaariese ulatust iseloomustakse DMFT indeksiga, mis näitab kaariesest 
kahjustatud (D), kaariese komplikatsioonide tõttu eemaldatud (M) ja täidistega 
(F) hammaste arvu uuritava kohta. Eestis on 12-aastaste keskmine DMFT 
indeks 2,7. See näitaja on lähedane Euroopa keskmisele (WHO järgi 2,6). See 
on madalam kui teistes Balti riikides, kuid tunduvalt kõrgem kui Skandinaavia-
maades. Põhjamaades on saavutatud tervete hammaste osakaalu tõus, kuna 
riiklikul tasemel on rakendatud ennetusprogramme ja tõstetud inimeste suu-
tervisealast teadlikkust. DMFT indeksi puuduseks on algavate kaarieskahjus-
tuste mittearvestamine – see ei võimalda seda indeksit kasutada kaariese arengu 
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jälgimiseks. Seetõttu loodi rahvusvahelise kaariese uurijate grupi poolt uus 
ICDAS süsteem (Ismail jt 2007), mis täiendavalt eristab kaariese varaseid 
staadiume, võimaldades jälgida dünaamikat, ja mida on kerge teisendada DMFT 
indeksiks. 
Nooremas koolieas toimub intensiivne hammaste vahetumine. Eestis puu-
duvad kaariese epidemioloogilised andmed selle vanusegrupi osas, kuid Olak jt 
(2007) on näidanud kõrget kaariesest haaratust väikelastel, seda eriti Kagu-Eesti 
piirkonnas. Piimahammaste kaaries soodustab omakorda kaariese arengut jääv-
hammastel. Seetõttu on kaariese preventsioon vahelduvas hammaskonnas väga 
oluline. 
Ajal, mil kliinilist uuringut alustati, puudusid pikaajalised polüoolide toimet 
võrdlevad uuringud, kuid erütritooli kasutamisel oli saadud positiivseid tule-
musi lühiajalistes kliinilistes uuringutes. 
 
Uurimistöö eesmärgid 
Peamiseks uuringu ülesandeks oli hinnata kaariese levimust noorema kooli-
astme õpilaste hulgas ja testida polüoolide pikaajalise kasutamise efektiivsust 
kaariese ennetuses. 
Uurimistöö alaeesmärkideks seati: 
1. Saada epidemioloogiline ülevaade kaariese levimusest jäävhammastel Kagu-
Eesti noorema kooliastme õpilastel vahelduvas hammaskonnas. 
2. Leida seos jäävmolaaride ja ajutiste molaaride kaariese esinemise vahel 
vahelduvas hammaskonnas. 
3. Testida ja võrrelda erinevate polüoolide ehk suhkuralkoholide (erütritool, 
külitool ning sorbitool positiivse kontrollainena) pikaajalise tarbimise mõju 
kaariese arengule vahelduvas hammaskonnas. 




Tegemist oli kolmeaastase topeltpimeda, randomiseeritud, prospektiivse sekku-
misuuringuga. Uuring viidi läbi Kagu-Eestis, kus kaariese näitajad on riigi 
kõrgeimad. Osales 10 kooli neljast erinevast maakonnast, mis moodustas 10% 
vastava piirkonna koolide koguarvust. Kõik lapsevanema või hooldaja poolt 
kirjaliku eelinformeeritud nõusoleku andnud 522 esimese ja teise klassi õpilast 
kaasati uuringusse. Esimesed klassid jaotati arvuti poolt juhuslikult genereeritud 
numbrite alusel kolme erinevasse gruppi (erütritooli, ksülitooli ja sorbitooli 
grupp) ja teised klassid ekvivalentselt nii, et igasse uuringugruppi kuuluks 
esmaselt vähemalt 151 last. Uuringu toimumiseks oli koolide juhtkonna nõus-
olek ning Tartu Ülikooli Eetikakomitee luba (protokoll 166/T-7). Kliiniline 
uuring registreeriti ka Ameerika Ühendriikide Rahvuslikus Tervise Instituudis 
identifitseerimisnumbriga NCT01062633. 
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Õpilaste kliiniline läbivaatus toimus Tartu Ülikooli Stomatoloogia kliinikus 
esmase läbivaatusena ja seejärel 12, 24 ja 36 kuu pärast. Läbivaatus teostati 
nelja eelkalibreeritud isiku poolt standartsel hambaravitoolil ja sisaldas kaaries-
kahjustuste registreerimist ICDAS II süsteemi kasutades ning hambakatu- ja 
süljenäidiste kogumist. Esmasel kliinilisel läbivaatusel osales 485 õpilast, kelle 
keskmine vanus oli 7,8 esimese klassi ja 8,8 aastat teise klassi õpilastel. Haiguse 
tõttu jäi kõrvale 37 õpilast (7,1% uuringus osalejatest). 
Uuringu toimumise päeva hommikul oli palutud lastel hambaid mitte pesta. 
Interdentaalse hambakatu näidised võeti kõigist sektoritest esimese jäävmolaari 
mesiaalselt küljelt mikroharjakesega, kandes näidised Orion Diagnostica 
(Espoo, Finland) Site Strips Test’ile. Hambakattu koguti diagnostilist sondi 
kasutades kolme minuti jooksul kõigilt vabalt juurdepääsetavatelt hamba-
pindadelt ja kaaluti koheselt, lahustati steriilses 0,9% NaCl lahuses ning 
külmutati –80°C juures edasisteks keemilisteks analüüsideks. Streptokokkide 
hulga määramiseks kasutati Dentocult® SM (Orion Diagnostica company; 
Espoo, Finland) komplekti kuuluvat spaatlit, mida roteeriti kergelt suletud suus. 
Lisaks koguti ja mõõdeti stimuleeritud sülje hulk ning kasutati seda lakto-
batsillide hulga määramise (Dentocult® LM; Orion Diagnostica) testis. 
Polüoolide tarbimise alusel moodustus kolm gruppi: erütritooli (n=165), 
ksülitooli (n=156) ja sorbitooli kui positiivse kontrolli rühm (n=164). Kõik 
polüooolid olid disainitud ja toodetud spetsiaalselt uuringu tarbeks Cargill R&D 
Centre Europe’s ning olid imemiseks mõeldud pelletid, mis sisaldasid ~90% 
toimeainet. Polüoole tarvitati kogu kooliaasta vältel kõigil koolipäevadel (~200 
päeval aastas) kolm korda koolipäeva jooksul: kohe kooli saabudes, lõunasöögi 
järgselt ja enne koolist lahkumist. Pastillide manustamist juhtisid ja kontrollisid 
klassijuhatajad. 
Kõik hambakatu keemilised analüüsid toimusid Belgias, Cargilli labora-
tooriumis, kus määrati suhkrute, orgaaniliste hapete ja kaltsiumi sisaldus katus. 
Statistilisteks analüüsideks kasutati epidemioloogiliste andmete jaoks esma-
sel läbivaatusel osalenud 485 lapse tulemusi ning kaariese dünaamika jälgimise 
ja polüoolide mõju hindamiseks kõigil neljal läbivaatustel osalenud 374 õpilase 
andmeid. Kõik olulisemad statistilised analüüsid tehti Turu Ülikooli ClinData 
Service osakonna statistiku poolt. 
 
Tulemused ja järeldused 
1. Kaariese esinemissagedus ja kaariesenäitajad Kagu-Eesti algklasside õpilaste 
hulgas on kõrged. Keskmine kaariese indeks (D4–6MFT) oli esimese klassi 
õpilastel 0,8 (SE=0,11) ja 1,1 (0,10) teise klassi õpilastel. Laste keskmine 
vanus esmasel läbivaatusel oli vastavalt 7,8 (SD=0,35) esimeses ja 8,8 
(SD=0,38) teises klassis. Kaariesest haaratus (D4–6MFT>0 ) esimeses klassis 
on 36.2% ja teises klassis juba 48.3%. Saadud tulemus sobitub eelnevate, 
teistes vanusegruppides läbi viidud uuringutulemustaga. Kaarieskahjustuste 
arv tõuseb kiirelt, olles peaaegu kõigi näitajate poolest teise klassi õpilastel 
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statistiliselt oluliselt kõrgem kui esimese klassi õpilastel. Seega on ennetus-
programmid selles vanuses väga olulised. 
2. ICDAS II kaariese registreerimise süsteem sobib kasutamiseks kliinilistes 
uuringutes, mis nõuavad kaarieskahjustuste dünaamika jälgimist. Leiti 
oluline seos (p<0,0001) jäävmolaaride ja ajutiste molaaride lingvaalsel ja 
oklusaalsel pinnal paiknevate dentiini ulatuvate kahjustuste vahel. Ravimata 
piimahambad suurendavad jäävhammaste kaariesest kahjustumise riski. 
3. Esimesed alumised jäävmolaarid (eriti nende mälumispinnad) on esimesena 
kahjustuvad jäävhambad. Täidiseid on 10,9%-l ülemistest ja 21,0%-l alu-
mistest esimestest jäävmolaaridest Kaaries saab alguse enamasti kohe peale 
hamba lõikumist ja selle ennetusena kasutatakse fissuuride katmist silanti-
dega, kuid nende arv uuritavate hulgas oli üllatavalt madal – 2,4% esimese- 
ja 3,9% teise klassi õpilastel. Dentiinikaariest (ICDAS koodid 4–6) esines 
kõige enam teistel piimamolaaridel, mis on ootuspärane, kuna tegemist on 
kõige kauem suus püsiva, viimasena vahetuva piimahambaga. 
4. Võrreldes sorbitooli ja ksülitooli grupiga oli erütritooli grupis kaariese areng 
aeglasem. Kõige selgemini avaldus see alates teisest uuringuaastast, olles 
aeglasem ka kolmandal aastal. Hilise avaldumise põhjuseks võib olla aeg, 
mis karioosse defekti välja kujunemiseks kulub – orienteeruvalt 2 aastat. 
Erütritooli kaariese kulgu pärssiv omadus laseb seda ainet soovitada ühe 
alternatiivse suhkruasendajana. 
5. Erütritooli grupis oli märgatavalt madalam nii hambakatu hulk (p<0.05), 
uuritavate hapete tase (p≤0.05) kui Streptococcus mutans´i hulk võrrelduna 
sorbitooli ja ksülitooli tarbinutega. See kinnitab erütritooli sobivust kaariese 
ennetuseks läbi hambakatu hulga ja koostise positiivsete muutuste. Ükski 
tarvitavatest polüoolidest ei mõjutanud laktobatsillide taset süljes. 
6. Sorbitool ja ksülitool selle uuringu jooksul kaariese arengule vahelduvas 
hammaskonnas mõju ei avaldanud. Eelnevad uuringud on tõestanud ksüli-
tooli kaariest vähendavat mõju, kuid antud uuringus jäi ksülitooli efekt 
tagasihoidlikuks. Üheks seletuseks võib olla väiksem päevase tarvitamis-
kordade arv – ametlikult soovitatava 4–5 korra asemel 3 korda päevas. 
Samuti ei tarbitud polüoole koolivälistel päevadel, kokku ~200 päeva 
jooksul aastas, mis jätab tarbimisse pika tühimiku. 
Vastavalt saadud uuringutulemustele võib erütritooli sisaldavaid tooteid 
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